{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:10:35Z","timestamp":1793333435774,"version":"4.5.0"},"reference-count":309,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05563-4","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T17:03:29Z","timestamp":1764263009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Advances in Intranasal Delivery of Exosomes for Central Nervous System Disorders"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-5006","authenticated-orcid":false,"given":"Babak","family":"Arjmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7431-1084","authenticated-orcid":false,"given":"Ali Reza","family":"Mojavezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2186-0276","authenticated-orcid":false,"given":"Amirhossein","family":"Kamroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Kalami","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1767-7475","authenticated-orcid":false,"given":"Mostafa","family":"Rezaei-Tavirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad-Sadegh","family":"Vahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"5563_CR1","doi-asserted-by":"publisher","unstructured":"Thangaleela S et al (2025) Nanoparticle-based imaging techniques in neurological disorders. In: Nanotechnology in the life sciences. Springer, Cham. p. 43\u2013107. https:\/\/doi.org\/10.1007\/978-3-031-80185-3_3","DOI":"10.1007\/978-3-031-80185-3_3"},{"key":"5563_CR2","doi-asserted-by":"publisher","unstructured":"Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK, Dua K, Cho H et al (2024) Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev 99:102357. https:\/\/doi.org\/10.1016\/j.arr.2024.102357","DOI":"10.1016\/j.arr.2024.102357"},{"issue":"9503","key":"5563_CR3","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri CP et al (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366(9503):2112\u20132117","journal-title":"Lancet"},{"issue":"8","key":"5563_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41578-024-00695-w","volume":"9","author":"J Gao","year":"2024","unstructured":"Gao J et al (2024) Precision drug delivery to the central nervous system using engineered nanoparticles. Nat Rev Mater 9(8):567\u2013588","journal-title":"Nat Rev Mater"},{"key":"5563_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.104971","author":"S Jarrin","year":"2021","unstructured":"Jarrin S, Cabr\u00e9 S, Dowd E (2021) The potential of biomaterials for central nervous system cellular repair. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2021.104971","journal-title":"Neurochem Int"},{"issue":"3","key":"5563_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/0929867329666220105122318","volume":"30","author":"S Rehman","year":"2023","unstructured":"Rehman S et al (2023) Nanoparticle mediated gene therapy: a trailblazer armament to fight CNS disorders. Curr Med Chem 30(3):304\u2013315","journal-title":"Curr Med Chem"},{"key":"5563_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113853","author":"J Wu","year":"2025","unstructured":"Wu J et al (2025) Intranasal delivery of mesenchymal stem cell-derived exosomes ameliorates experimental autoimmune encephalomyelitis. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2024.113853","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"5563_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.addr.2012.06.014","volume":"65","author":"A Tan","year":"2013","unstructured":"Tan A, Rajadas J, Seifalian AM (2013) Exosomes as nano-theranostic delivery platforms for gene therapy. Adv Drug Deliv Rev 65(3):357\u2013367","journal-title":"Adv Drug Deliv Rev"},{"key":"5563_CR9","doi-asserted-by":"publisher","unstructured":"Al-Shubaily FA (2020) Characterization and fine structure of exosomes, in role of exosomes in biological communication systems. Springer, Singapore, pp 27\u201375.\u00a0https:\/\/doi.org\/10.1007\/978-981-15-6599-1_2","DOI":"10.1007\/978-981-15-6599-1_2"},{"key":"5563_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biology12050710","author":"J Aseervatham","year":"2023","unstructured":"Aseervatham J (2023) Dynamic role of exosome microRNAs in cancer cell signaling and their emerging role as noninvasive biomarkers. Biology (Basel). https:\/\/doi.org\/10.3390\/biology12050710","journal-title":"Biology (Basel)"},{"issue":"6","key":"5563_CR11","first-page":"411","volume":"46","author":"SS Li","year":"2019","unstructured":"Li SS et al (2019) Characteristics and functions of exosomes from different cell sources. J Int Pharm Res 46(6):411\u2013417","journal-title":"J Int Pharm Res"},{"key":"5563_CR12","doi-asserted-by":"publisher","unstructured":"Wang Y et al (2024) The regulation of exosome generation and function in physiological and pathological processes. Intl J Mol Sci 25(1):255. https:\/\/doi.org\/10.3390\/ijms25010255","DOI":"10.3390\/ijms25010255"},{"key":"5563_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00318","author":"P Ranjan","year":"2019","unstructured":"Ranjan P, Kumari R, Verma SK (2019) Cardiac fibroblasts and cardiac fibrosis: precise role of exosomes. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2019.00318","journal-title":"Front Cell Dev Biol"},{"key":"5563_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201702153","author":"K Boriachek","year":"2018","unstructured":"Boriachek K et al (2018) Biological functions and current advances in isolation and detection strategies for exosome nanovesicles. Small. https:\/\/doi.org\/10.1002\/smll.201702153","journal-title":"Small"},{"issue":"2","key":"5563_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00018-020-03619-3","volume":"78","author":"D Gagliardi","year":"2021","unstructured":"Gagliardi D et al (2021) Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers. Cell Mol Life Sci 78(2):561\u2013572","journal-title":"Cell Mol Life Sci"},{"key":"5563_CR16","doi-asserted-by":"publisher","unstructured":"Ambrosini G et al (2020) Use of antibody arrays to probe exosome and extracellular vesicle mediated functional changes in cells. In: Methods in Enzymology, p. 43\u201353. https:\/\/doi.org\/10.1016\/bs.mie.2020.09.003","DOI":"10.1016\/bs.mie.2020.09.003"},{"key":"5563_CR17","doi-asserted-by":"publisher","unstructured":"Sancho-Albero M, Sebasti\u00e1n V (2023) Isolation of extracellular vesicles by a microfluidic platform to diagnose and monitor pancreatic cancer. In: Methods in molecular biology. Humana, New York, NY. p. 181\u2013191. https:\/\/doi.org\/10.1007\/978-1-0716-3271-0_12","DOI":"10.1007\/978-1-0716-3271-0_12"},{"issue":"9","key":"5563_CR18","first-page":"28","volume":"40","author":"Y Wu","year":"2020","unstructured":"Wu Y, Xin L (2020) New drug delivery system: delivery of exosomes as drug carriers. Chin Biotechnol 40(9):28\u201335","journal-title":"Chin Biotechnol"},{"issue":"4","key":"5563_CR19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2174\/156652312802083594","volume":"12","author":"AJ O'Loughlin","year":"2012","unstructured":"O\u2019Loughlin AJ, Woffindale CA, Wood MJA (2012) Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther 12(4):262\u2013274","journal-title":"Curr Gene Ther"},{"issue":"1","key":"5563_CR20","first-page":"1","volume":"13","author":"A Ortega","year":"2021","unstructured":"Ortega A et al (2021) Exosomes as drug delivery systems: endogenous nanovehicles for treatment of systemic lupus erythematosus. Pharmaceutics 13(1):1\u201328","journal-title":"Pharmaceutics"},{"issue":"5","key":"5563_CR21","first-page":"771","volume":"48","author":"J Wu","year":"2023","unstructured":"Wu J, Li S, Zhang Y (2023) Research progress in role of exosomes exosomes in mental disorders. Journal of Central South University (Medical Sciences) 48(5):771\u2013781","journal-title":"J Central South Univ (Medical Sciences)"},{"issue":"1","key":"5563_CR22","first-page":"55","volume":"2","author":"L Xiao","year":"2021","unstructured":"Xiao L, Hareendran S, Loh YP (2021) Function of exosomes in neurological disorders and brain tumors. Extracell Vesicles Circ Nucleic Acids 2(1):55\u201379","journal-title":"Extracell Vesicles Circ Nucleic Acids"},{"key":"5563_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6640836","author":"Q Jin","year":"2021","unstructured":"Jin Q et al (2021) Extracellular vesicles: novel roles in neurological disorders. Stem Cells Int. https:\/\/doi.org\/10.1155\/2021\/6640836","journal-title":"Stem Cells Int"},{"key":"5563_CR24","unstructured":"Ge J, Shen L (2022) Research progress of the exosomes in diagnosis and treatment of central nervous system diseases. Chin J Appl Clin Pediatr 37(13):1034\u20131037"},{"issue":"3","key":"5563_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12264-016-0092-z","volume":"33","author":"X Wu","year":"2017","unstructured":"Wu X, Zheng T, Zhang B (2017) Exosomes in Parkinson\u2019s disease. Neurosci Bull 33(3):331\u2013338","journal-title":"Neurosci Bull"},{"issue":"3","key":"5563_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bbadis.2015.09.020","volume":"1862","author":"KM Kanninen","year":"2016","unstructured":"Kanninen KM et al (2016) Exosomes as new diagnostic tools in CNS diseases. Biochim Biophys Acta Mol Basis Dis 1862(3):403\u2013410","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"12","key":"5563_CR27","first-page":"1524","volume":"37","author":"N Zhang","year":"2016","unstructured":"Zhang N, Zhang RJ, Sun XJ (2016) Research progress of exosomes in diseases of the central nervous system. Acad J Second Mil Univ 37(12):1524\u20131527","journal-title":"Acad J Second Mil Univ"},{"issue":"12","key":"5563_CR28","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.1007\/s12035-022-03028-6","volume":"59","author":"L Zhang","year":"2022","unstructured":"Zhang L, Mao L, Wang H (2022) The neuroprotection effects of exosome in central nervous system injuries: a new target for therapeutic intervention. Mol Neurobiol 59(12):7152\u20137169","journal-title":"Mol Neurobiol"},{"key":"5563_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1271489","author":"J Zhao","year":"2023","unstructured":"Zhao J et al (2023) Biomedical applications of artificial exosomes for intranasal drug delivery. Front Bioeng Biotechnol. https:\/\/doi.org\/10.3389\/fbioe.2023.1271489","journal-title":"Front Bioeng Biotechnol"},{"issue":"6","key":"5563_CR30","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4103\/1673-5374.385875","volume":"19","author":"S Gotoh","year":"2024","unstructured":"Gotoh S, Kawabori M, Fujimura M (2024) Intranasal administration of stem cell-derived exosomes for central nervous system diseases. Neural Regen Res 19(6):1249\u20131255","journal-title":"Neural Regen Res"},{"issue":"12","key":"5563_CR31","first-page":"3199","volume":"59","author":"P Xian","year":"2024","unstructured":"Xian P et al (2024) Advances in the strategies of nasal into brain nanodelivery and the treatment of brain diseases. Yaoxue Xuebao 59(12):3199\u20133214","journal-title":"Yaoxue Xuebao"},{"key":"5563_CR32","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02946-z","author":"M Butola","year":"2024","unstructured":"Butola M, Nainwal N (2024) Non-invasive techniques of nose to brain delivery using nanoparticulate carriers: hopes and hurdles. AAPS PharmSciTech. https:\/\/doi.org\/10.1208\/s12249-024-02946-z","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"5563_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018024697","volume":"35","author":"Y Fan","year":"2018","unstructured":"Fan Y et al (2018) Updated progress of nanocarrier-based intranasal drug delivery systems for treatment of brain diseases. Crit Rev Ther Drug Carrier Syst 35(5):433\u2013468","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"5563_CR34","doi-asserted-by":"publisher","unstructured":"Kushwaha S, Kushwaha N, Paswan A (2024) An update on the potential of nanocarriers for intranasal delivery. Lett Appl NanoBioScience 13(1). https:\/\/doi.org\/10.33263\/LIANBS131.016","DOI":"10.33263\/LIANBS131.016"},{"key":"5563_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071992","author":"NCH Lau","year":"2023","unstructured":"Lau NCH, Yam JWP (2023) From exosome biogenesis to absorption: key takeaways for cancer research. Cancers. https:\/\/doi.org\/10.3390\/cancers15071992","journal-title":"Cancers"},{"issue":"2","key":"5563_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1042\/EBC20170076","volume":"62","author":"R Palmulli","year":"2018","unstructured":"Palmulli R, Van Niel G (2018) To be or not to be... secreted as exosomes, a balance finely tuned by the mechanisms of biogenesis. Essays Biochem 62(2):177\u2013191","journal-title":"Essays Biochem"},{"issue":"7","key":"5563_CR37","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/cdd.2010.184","volume":"18","author":"R Alonso","year":"2011","unstructured":"Alonso R et al (2011) Diacylglycerol kinase \u03b1 regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligand-containing exosomes in T lymphocytes. Cell Death Differ 18(7):1161\u20131173","journal-title":"Cell Death Differ"},{"key":"5563_CR38","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022110698","author":"FL Li","year":"2022","unstructured":"Li FL et al (2022) Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB. EMBO J. https:\/\/doi.org\/10.15252\/embj.2022110698","journal-title":"EMBO J"},{"issue":"1","key":"5563_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/cdd.2015.72","volume":"23","author":"C Mazzeo","year":"2016","unstructured":"Mazzeo C et al (2016) Protein kinase D1\/2 is involved in the maturation of multivesicular bodies and secretion of exosomes in T and B lymphocytes. Cell Death Differ 23(1):99\u2013109","journal-title":"Cell Death Differ"},{"issue":"22","key":"5563_CR40","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.cub.2009.09.059","volume":"19","author":"V Muralidharan-Chari","year":"2009","unstructured":"Muralidharan-Chari V et al (2009) ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 19(22):1875\u20131885","journal-title":"Curr Biol"},{"key":"5563_CR41","doi-asserted-by":"publisher","unstructured":"Park JB et al (2004) Regulation of phospholipase D2 by GTP-dependent interaction with dynamin. In: Advances in Enzyme Regulation. 44:249-64. https:\/\/doi.org\/10.1016\/j.advenzreg.2003.11.021","DOI":"10.1016\/j.advenzreg.2003.11.021"},{"issue":"2","key":"5563_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1600-0854.2004.00257.x","volume":"6","author":"A Savina","year":"2005","unstructured":"Savina A et al (2005) Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 6(2):131\u2013143","journal-title":"Traffic"},{"issue":"11","key":"5563_CR43","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.biocel.2006.04.006","volume":"38","author":"EM van Dam","year":"2006","unstructured":"van Dam EM, Robinson PJ (2006) Ral: mediator of membrane trafficking. Int J Biochem Cell Biol 38(11):1841\u20131847","journal-title":"Int J Biochem Cell Biol"},{"issue":"33","key":"5563_CR44","doi-asserted-by":"publisher","first-page":"29921","DOI":"10.1074\/jbc.M413748200","volume":"280","author":"N Vitale","year":"2005","unstructured":"Vitale N et al (2005) The small GTPase RalA controls exocytosis of large dense core secretory granules by interacting with ARF6-dependent phospholipase D1. J Biol Chem 280(33):29921\u201329928","journal-title":"J Biol Chem"},{"key":"5563_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13010084","author":"H Aheget","year":"2020","unstructured":"Aheget H et al (2020) Exosomes: their role in pathogenesis, diagnosis and treatment of diseases. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13010084","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5563_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C et al (2018) Exosome theranostics: biology and translational medicine. Theranostics 8(1):237\u2013255","journal-title":"Theranostics"},{"key":"5563_CR47","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v1i0.18396","author":"OG de Jong","year":"2012","unstructured":"de Jong OG et al (2012) Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles. https:\/\/doi.org\/10.3402\/jev.v1i0.18396","journal-title":"J Extracell Vesicles"},{"key":"5563_CR48","doi-asserted-by":"publisher","unstructured":"Jordan S, Haroon J (2024) The role of exosomes in regenerative medicine, in Essentials of regenerative medicine in interventional pain management, second edition. Springer, Cham. p. 195\u2013203. https:\/\/doi.org\/10.1007\/978-3-031-50357-3_13","DOI":"10.1007\/978-3-031-50357-3_13"},{"key":"5563_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155214","author":"S Khoushab","year":"2024","unstructured":"Khoushab S et al (2024) Unlocking the potential of exosomes in cancer research: a paradigm shift in diagnosis, treatment, and prevention. Pathology. https:\/\/doi.org\/10.1016\/j.prp.2024.155214","journal-title":"Pathology"},{"key":"5563_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3634563","author":"LL Yu","year":"2018","unstructured":"Yu LL et al (2018) A comparison of traditional and novel methods for the separation of exosomes from human samples. Biomed Res Int. https:\/\/doi.org\/10.1155\/2018\/3634563","journal-title":"Biomed Res Int"},{"issue":"1-2","key":"5563_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijpharm.2017.02.038","volume":"521","author":"XC Jiang","year":"2017","unstructured":"Jiang XC, Gao JQ (2017) Exosomes as novel bio-carriers for gene and drug delivery. Int J Pharm 521(1\u20132):167\u2013175. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.038","journal-title":"Int J Pharm"},{"key":"5563_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3356467","author":"NA Clinton","year":"2022","unstructured":"Clinton NA et al (2022) Harnessing the therapeutic potential of exosomes: a novel strategy for anticancer and antiviral therapy. Biomed Res Int. https:\/\/doi.org\/10.1155\/2022\/3356467","journal-title":"Biomed Res Int"},{"issue":"1","key":"5563_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/prd.12561","volume":"94","author":"RJ Miron","year":"2024","unstructured":"Miron RJ et al (2024) Understanding exosomes: part 2\u2014emerging leaders in regenerative medicine. Periodontol 2000 94(1):257\u2013414","journal-title":"Periodontol 2000"},{"issue":"5","key":"5563_CR54","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s13402-023-00810-z","volume":"46","author":"G Patel","year":"2023","unstructured":"Patel G et al (2023) Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer. Cell Oncol 46(5):1159\u20131179","journal-title":"Cell Oncol"},{"key":"5563_CR55","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2023.04.038","volume":"358","author":"A Macedo-Pereira","year":"2023","unstructured":"Macedo-Pereira A et al (2023) Digging the intercellular crosstalk via extracellular vesicles: may exosomes be the drug delivery solution for target glioblastoma? J Control Release 358:98\u2013115","journal-title":"J Control Release"},{"issue":"12","key":"5563_CR56","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1007\/s12035-018-1054-4","volume":"55","author":"N Osier","year":"2018","unstructured":"Osier N et al (2018) Exosomes in acquired neurological disorders: new insights into pathophysiology and treatment. Mol Neurobiol 55(12):9280\u20139293","journal-title":"Mol Neurobiol"},{"issue":"3","key":"5563_CR57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/0118756921285480240118051820","volume":"20","author":"N Minocha","year":"2023","unstructured":"Minocha N, Sardana S (2023) Exosome and other extracellular vesicles in gene therapy and personalized care. Curr Pharmacogenomics Person Med 20(3):135\u2013145","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"5563_CR58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney MJ et al (2015) Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release 207:18\u201330","journal-title":"J Control Release"},{"issue":"26","key":"5563_CR59","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.7150\/thno.37097","volume":"9","author":"S Walker","year":"2019","unstructured":"Walker S et al (2019) Extracellular vesicle-based drug delivery systems for cancer treatment. Theranostics 9(26):8001","journal-title":"Theranostics"},{"issue":"1","key":"5563_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-020-00633-2","volume":"27","author":"YW Wu","year":"2020","unstructured":"Wu YW et al (2020) Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop. J Biomed Sci 27(1):45","journal-title":"J Biomed Sci"},{"issue":"9","key":"5563_CR61","doi-asserted-by":"publisher","first-page":"9568","DOI":"10.1021\/acsnano.8b05377","volume":"12","author":"D Ingato","year":"2018","unstructured":"Ingato D et al (2018) Cancer cell-derived, drug-loaded nanovesicles induced by sulfhydryl-blocking for effective and safe cancer therapy. ACS Nano 12(9):9568\u20139577","journal-title":"ACS Nano"},{"issue":"3","key":"5563_CR62","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/pharmaceutics12030226","volume":"12","author":"G Carobolante","year":"2020","unstructured":"Carobolante G et al (2020) Cow milk and intestinal epithelial cell-derived extracellular vesicles as systems for enhancing oral drug delivery. Pharmaceutics 12(3):226","journal-title":"Pharmaceutics"},{"key":"5563_CR63","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","volume":"220","author":"H Saari","year":"2015","unstructured":"Saari H et al (2015) Microvesicle-and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Control Release 220:727\u2013737","journal-title":"J Control Release"},{"issue":"5","key":"5563_CR64","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.nano.2017.03.001","volume":"13","author":"AK Agrawal","year":"2017","unstructured":"Agrawal AK et al (2017) Milk-derived exosomes for oral delivery of paclitaxel. Nanomedicine Nanotechnol Biol Med 13(5):1627\u20131636","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"5563_CR65","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ijpharm.2019.06.028","volume":"566","author":"PH Tran","year":"2019","unstructured":"Tran PH et al (2019) Development of a nanoamorphous exosomal delivery system as an effective biological platform for improved encapsulation of hydrophobic drugs. Int J Pharm 566:697\u2013707","journal-title":"Int J Pharm"},{"key":"5563_CR66","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S179380","author":"X Yang","year":"2018","unstructured":"Yang X et al (2018) Exosome-encapsulated antibiotic against intracellular infections of methicillin-resistant Staphylococcus aureus. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S179380","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"5563_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-019-0526-7","volume":"17","author":"C Gong","year":"2019","unstructured":"Gong C et al (2019) Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy. J Nanobiotechnology 17(1):93","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"5563_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-019-0461-7","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H et al (2019) Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice. J Nanobiotechnology 17(1):29","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"5563_CR69","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1208\/s12248-016-0015-y","volume":"19","author":"T Yang","year":"2017","unstructured":"Yang T et al (2017) Delivery of small interfering RNA to inhibit vascular endothelial growth factor in zebrafish using natural brain endothelia cell-secreted exosome nanovesicles for the treatment of brain cancer. AAPS J 19(2):475\u2013486","journal-title":"AAPS J"},{"issue":"3","key":"5563_CR70","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s11481-019-09864-z","volume":"15","author":"K Liao","year":"2020","unstructured":"Liao K et al (2020) Intranasal delivery of lincRNA-Cox2 siRNA loaded extracellular vesicles decreases lipopolysaccharide-induced microglial proliferation in mice. J Neuroimmune Pharmacol 15(3):390\u2013399","journal-title":"J Neuroimmune Pharmacol"},{"key":"5563_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jconrel.2014.11.029","volume":"205","author":"G Fuhrmann","year":"2015","unstructured":"Fuhrmann G et al (2015) Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release 205:35\u201344","journal-title":"J Control Release"},{"issue":"2","key":"5563_CR72","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/pr9020356","volume":"9","author":"Y Han","year":"2021","unstructured":"Han Y et al (2021) Overview and update on methods for cargo loading into extracellular vesicles. Processes 9(2):356","journal-title":"Processes"},{"key":"5563_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113690","volume":"155","author":"NF Hosseini","year":"2022","unstructured":"Hosseini NF, Amini R, Ramezani M, Saidijam M, Hashemi SM, Najafi R (2022) AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer. Biomed Pharmacother 155:113690. https:\/\/doi.org\/10.1016\/j.biopha.2022.113690","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5563_CR74","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","volume":"31","author":"S Sadeghi","year":"2023","unstructured":"Sadeghi S et al (2023) Exosome engineering in cell therapy and drug delivery. Inflammopharmacology 31(1):145\u2013169","journal-title":"Inflammopharmacology"},{"issue":"1","key":"5563_CR75","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v5.32538","volume":"5","author":"T Martins-Marques","year":"2016","unstructured":"Martins-Marques T et al (2016) Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti-tumour therapeutic approach with doxorubicin. J Extracell Vesicles 5(1):32538","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"5563_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214545","volume":"14","author":"C Schindler","year":"2019","unstructured":"Schindler C et al (2019) Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency. PLoS One 14(3):e0214545","journal-title":"PLoS One"},{"key":"5563_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118762","volume":"572","author":"T Takenaka","year":"2019","unstructured":"Takenaka T et al (2019) Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells. Int J Pharm 572:118762","journal-title":"Int J Pharm"},{"issue":"1","key":"5563_CR78","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1021\/acsnano.6b05630","volume":"11","author":"W Zhang","year":"2017","unstructured":"Zhang W et al (2017) Magnetic and folate functionalization enables rapid isolation and enhanced tumor-targeting of cell-derived microvesicles. ACS Nano 11(1):277\u2013290","journal-title":"ACS Nano"},{"key":"5563_CR79","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biomaterials.2018.06.029","volume":"178","author":"G Jia","year":"2018","unstructured":"Jia G et al (2018) NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials 178:302\u2013316","journal-title":"Biomaterials"},{"issue":"3","key":"5563_CR80","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","volume":"12","author":"MS Kim","year":"2016","unstructured":"Kim MS et al (2016) Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine Nanotechnol Biol Med 12(3):655\u2013664","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"5563_CR81","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S154458","author":"G Liang","year":"2018","unstructured":"Liang G et al (2018) Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S154458","journal-title":"Int J Nanomedicine"},{"key":"5563_CR82","first-page":"133","volume":"13","author":"MAC Pomatto","year":"2019","unstructured":"Pomatto MAC et al (2019) Improved loading of plasma-derived extracellular vesicles to encapsulate antitumor miRNAs. Mol Ther 13:133\u2013144","journal-title":"Mol Ther"},{"issue":"9","key":"5563_CR83","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/thoraxjnl-2018-212994","volume":"74","author":"D Zhang","year":"2019","unstructured":"Zhang D et al (2019) A potential role of microvesicle-containing miR-223\/142 in lung inflammation. Thorax 74(9):865\u2013874","journal-title":"Thorax"},{"issue":"1","key":"5563_CR84","doi-asserted-by":"publisher","first-page":"10721","DOI":"10.1038\/srep10721","volume":"5","author":"S Bala","year":"2015","unstructured":"Bala S et al (2015) Biodistribution and function of extracellular miRNA-155 in mice. Sci Rep 5(1):10721","journal-title":"Sci Rep"},{"key":"5563_CR85","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.lfs.2019.01.005","volume":"219","author":"A Asadirad","year":"2019","unstructured":"Asadirad A et al (2019) Phenotypical and functional evaluation of dendritic cells after exosomal delivery of miRNA-155. Life Sci 219:152\u2013162","journal-title":"Life Sci"},{"issue":"1","key":"5563_CR86","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1650595","volume":"8","author":"S Ramanathan","year":"2019","unstructured":"Ramanathan S et al (2019) Inflammation potentiates miR-939 expression and packaging into small extracellular vesicles. J Extracell Vesicles 8(1):1650595","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"5563_CR87","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341\u2013345","journal-title":"Nat Biotechnol"},{"key":"5563_CR88","doi-asserted-by":"publisher","unstructured":"Banizs AB et al (2014) In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery. Intl J Nanomed 4223\u20134230. https:\/\/doi.org\/10.2147\/IJN.S64267","DOI":"10.2147\/IJN.S64267"},{"key":"5563_CR89","doi-asserted-by":"publisher","first-page":"241. e1","DOI":"10.1016\/j.urology.2016.01.028","volume":"91","author":"KA Greco","year":"2016","unstructured":"Greco KA et al (2016) PLK-1 silencing in bladder cancer by siRNA delivered with exosomes. Urology 91:241. e1-241. e7","journal-title":"Urology"},{"issue":"5","key":"5563_CR90","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.7150\/thno.16532","volume":"7","author":"Y Wang","year":"2017","unstructured":"Wang Y et al (2017) Nucleolin-targeted extracellular vesicles as a versatile platform for biologics delivery to breast cancer. Theranostics 7(5):1360","journal-title":"Theranostics"},{"issue":"8","key":"5563_CR91","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99263","volume":"3","author":"M Mendt","year":"2018","unstructured":"Mendt M et al (2018) Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight 3(8):e99263","journal-title":"JCI Insight"},{"issue":"1","key":"5563_CR92","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12010-018-2813-4","volume":"187","author":"SK Limoni","year":"2019","unstructured":"Limoni SK et al (2019) Engineered exosomes for targeted transfer of siRNA to HER2 positive breast cancer cells. Appl Biochem Biotechnol 187(1):352\u2013364","journal-title":"Appl Biochem Biotechnol"},{"issue":"10","key":"5563_CR93","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1021\/acs.molpharmaceut.5b00364","volume":"12","author":"TN Lamichhane","year":"2015","unstructured":"Lamichhane TN, Raiker RS, Jay SM (2015) Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery. Mol Pharm 12(10):3650\u20133657","journal-title":"Mol Pharm"},{"issue":"11","key":"5563_CR94","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau6762","volume":"4","author":"C-Y Kao","year":"2018","unstructured":"Kao C-Y, Papoutsakis ET (2018) Engineering human megakaryocytic microparticles for targeted delivery of nucleic acids to hematopoietic stem and progenitor cells. Sci Adv 4(11):eaau6762","journal-title":"Sci Adv"},{"key":"5563_CR95","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jconrel.2017.09.013","volume":"266","author":"SM Kim","year":"2017","unstructured":"Kim SM et al (2017) Cancer-derived exosomes as a delivery platform of CRISPR\/Cas9 confer cancer cell tropism-dependent targeting. J Control Release 266:8\u201316","journal-title":"J Control Release"},{"issue":"1","key":"5563_CR96","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","volume":"172","author":"SAA Kooijmans","year":"2013","unstructured":"Kooijmans SAA et al (2013) Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Control Release 172(1):229\u2013238","journal-title":"J Control Release"},{"issue":"5","key":"5563_CR97","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s10616-016-9952-7","volume":"68","author":"KB Johnsen","year":"2016","unstructured":"Johnsen KB et al (2016) Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes. Cytotechnology 68(5):2125\u20132138","journal-title":"Cytotechnology"},{"key":"5563_CR98","doi-asserted-by":"crossref","unstructured":"Chen H et al\u00a0(2021) Exosomes, a new star for targeted delivery. Front Cell Dev Biol\u00a09:2021","DOI":"10.3389\/fcell.2021.751079"},{"issue":"1","key":"5563_CR99","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nano.2017.09.011","volume":"14","author":"MS Kim","year":"2018","unstructured":"Kim MS et al (2018) Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. Nanomedicine Nanotechnol Biol Med 14(1):195\u2013204","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"issue":"2","key":"5563_CR100","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s40199-019-00280-5","volume":"27","author":"S Salarpour","year":"2019","unstructured":"Salarpour S et al (2019) Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. DARU J Pharm Sci 27(2):533\u2013539","journal-title":"DARU J Pharm Sci"},{"key":"5563_CR101","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3389\/fncel.2019.00530","volume":"13","author":"GM Kalinec","year":"2019","unstructured":"Kalinec GM et al (2019) Extracellular vesicles from auditory cells as nanocarriers for anti-inflammatory drugs and pro-resolving mediators. Front Cell Neurosci 13:530","journal-title":"Front Cell Neurosci"},{"issue":"6_suppl","key":"5563_CR102","doi-asserted-by":"publisher","first-page":"52S","DOI":"10.1177\/0003489419836226","volume":"128","author":"GM Kalinec","year":"2019","unstructured":"Kalinec GM et al (2019) Preliminary characterization of extracellular vesicles from auditory HEI-OC1 cells. Ann Otol Rhinol Laryngol 128(6_suppl):52S-60S","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"10","key":"5563_CR103","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1111\/cas.14181","volume":"110","author":"M Yu","year":"2019","unstructured":"Yu M et al (2019) Targeted exosome\u2010encapsulated erastin induced ferroptosis in triple negative breast cancer cells. Cancer Sci 110(10):3173\u20133182","journal-title":"Cancer Sci"},{"issue":"3","key":"5563_CR104","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12195-016-0457-4","volume":"9","author":"TN Lamichhane","year":"2016","unstructured":"Lamichhane TN et al (2016) Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication. Cell Mol Bioeng 9(3):315\u2013324","journal-title":"Cell Mol Bioeng"},{"issue":"11","key":"5563_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801271","volume":"8","author":"MJ Haney","year":"2019","unstructured":"Haney MJ et al (2019) TPP1 delivery to lysosomes with extracellular vesicles and their enhanced brain distribution in the animal model of batten disease. Adv Healthc Mater 8(11):1801271","journal-title":"Adv Healthc Mater"},{"key":"5563_CR106","doi-asserted-by":"publisher","DOI":"10.1039\/D4NA00501E","author":"SS Palakurthi","year":"2024","unstructured":"Palakurthi SS et al (2024) A comprehensive review of challenges and advances in exosome-based drug delivery systems. Nanoscale Adv. https:\/\/doi.org\/10.1039\/D4NA00501E","journal-title":"Nanoscale Adv"},{"issue":"3","key":"5563_CR107","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11481-019-09884-9","volume":"15","author":"MJ Haney","year":"2020","unstructured":"Haney MJ et al (2020) Macrophage-derived extracellular vesicles as drug delivery systems for triple negative breast cancer (TNBC) therapy. J Neuroimmune Pharmacol 15(3):487\u2013500","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"5563_CR108","first-page":"6681771","volume":"2021","author":"L Luo","year":"2021","unstructured":"Luo L, Avery SJ, Waddington RJ (2021) Exploring a chemotactic role for EVs from progenitor cell populations of human exfoliated deciduous teeth for promoting migration of na\u00efve BMSCs in bone repair process. Stem Cells Int 2021(1):6681771","journal-title":"Stem Cells Int"},{"key":"5563_CR109","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S131786","author":"WJ Goh","year":"2017","unstructured":"Goh WJ et al (2017) Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S131786","journal-title":"Int J Nanomedicine"},{"key":"5563_CR110","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","volume":"150","author":"T Tian","year":"2018","unstructured":"Tian T et al (2018) Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials 150:137\u2013149","journal-title":"Biomaterials"},{"key":"5563_CR111","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.biocel.2016.09.002","volume":"79","author":"A Kalani","year":"2016","unstructured":"Kalani A et al (2016) Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury. Int J Biochem Cell Biol 79:360\u2013369","journal-title":"Int J Biochem Cell Biol"},{"key":"5563_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118786","volume":"572","author":"PH Tran","year":"2019","unstructured":"Tran PH, Tran PHL, Wang T, Yin W, Tran TTD, Nguyen TNG, Lee B-J, Duan W (2019) Aspirin-loaded nanoexosomes as cancer therapeutics. Int J Pharm 572:118786. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118786","journal-title":"Int J Pharm"},{"issue":"7","key":"5563_CR113","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1002\/jcb.29657","volume":"121","author":"G Won Lee","year":"2020","unstructured":"Won Lee G et al (2020) Exosome mediated transfer of miRNA\u2010140 promotes enhanced chondrogenic differentiation of bone marrow stem cells for enhanced cartilage repair and regeneration. J Cell Biochem 121(7):3642\u20133652","journal-title":"J Cell Biochem"},{"key":"5563_CR114","doi-asserted-by":"publisher","first-page":"21933","DOI":"10.1038\/srep21933","volume":"6","author":"YT Sato","year":"2016","unstructured":"Sato YT et al (2016) Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep 6:21933","journal-title":"Sci Rep"},{"issue":"6","key":"5563_CR115","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"Luan X et al (2017) Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38(6):754\u2013763","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"5563_CR116","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1021\/acsbiomaterials.1c00217","volume":"7","author":"MN Huda","year":"2021","unstructured":"Huda MN et al (2021) Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications. ACS Biomater Sci Eng 7(6):2106\u20132149","journal-title":"ACS Biomater Sci Eng"},{"key":"5563_CR117","first-page":"63","volume-title":"Immunocytochemical methods and protocols","author":"MC Jamur","year":"2009","unstructured":"Jamur MC, Oliver C (2009) Permeabilization of cell membranes. Immunocytochemical methods and protocols. Springer, pp 63\u201366"},{"issue":"19","key":"5563_CR118","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.7150\/thno.33925","volume":"9","author":"X Zou","year":"2019","unstructured":"Zou X et al (2019) Extracellular vesicles expressing a single-chain variable fragment of an HIV-1 specific antibody selectively target Env+ tissues. Theranostics 9(19):5657","journal-title":"Theranostics"},{"issue":"40","key":"5563_CR119","doi-asserted-by":"publisher","first-page":"18825","DOI":"10.1039\/C9NR06183E","volume":"11","author":"M Sancho-Albero","year":"2019","unstructured":"Sancho-Albero M et al (2019) Efficient encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to obtain hollow gold nanoparticle-hybrids. Nanoscale 11(40):18825\u201318836","journal-title":"Nanoscale"},{"issue":"15","key":"5563_CR120","doi-asserted-by":"publisher","first-page":"1706616","DOI":"10.1002\/adma.201706616","volume":"30","author":"G Fuhrmann","year":"2018","unstructured":"Fuhrmann G et al (2018) Engineering extracellular vesicles with the tools of enzyme prodrug therapy. Adv Mater 30(15):1706616","journal-title":"Adv Mater"},{"issue":"sup3","key":"5563_CR121","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/21691401.2018.1489824","volume":"46","author":"L Zhu","year":"2018","unstructured":"Zhu L et al (2018) Novel alternatives to extracellular vesicle-based immunotherapy\u2013exosome mimetics derived from natural killer cells. Artif Cells Nanomed Biotechnol 46(sup3):166\u2013179","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"5563_CR122","first-page":"147","volume-title":"Bio-carrier vectors: methods and protocols","author":"Y-H Ou","year":"2020","unstructured":"Ou Y-H et al (2020) Cell-derived nanovesicles as exosome-mimetics for drug delivery purposes: uses and recommendations. Bio-carrier vectors: methods and protocols. Springer, pp 147\u2013170"},{"issue":"1","key":"5563_CR123","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12645-023-00166-x","volume":"14","author":"M Meng","year":"2023","unstructured":"Meng M et al (2023) Engineering M1-derived nanovesicles loading with docosahexaenoic acid synergizes ferroptosis and immune activation for treating hepatocellular carcinoma. Cancer Nanotechnol 14(1):17","journal-title":"Cancer Nanotechnol"},{"issue":"1","key":"5563_CR124","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1021\/acs.biomac.7b01176","volume":"19","author":"WJ Goh","year":"2018","unstructured":"Goh WJ et al (2018) EXOPLEXs: chimeric drug delivery platform from the fusion of cell-derived nanovesicles and liposomes. Biomacromol 19(1):22\u201330","journal-title":"Biomacromol"},{"issue":"2","key":"5563_CR125","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/antiox12020473","volume":"12","author":"YJ Jang","year":"2023","unstructured":"Jang YJ et al (2023) Extracellular vesicles, as drug-delivery vehicles, improve the biological activities of astaxanthin. Antioxidants 12(2):473","journal-title":"Antioxidants"},{"issue":"8","key":"5563_CR126","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.3390\/cells9081797","volume":"9","author":"J Van Deun","year":"2020","unstructured":"Van Deun J et al (2020) Feasibility of mechanical extrusion to coat nanoparticles with extracellular vesicle membranes. Cells 9(8):1797","journal-title":"Cells"},{"key":"5563_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100760","volume":"22","author":"X Xu","year":"2023","unstructured":"Xu X et al (2023) Programming assembly of biomimetic exosomes: an emerging theranostic nanomedicine platform. Mater Today Bio 22:100760","journal-title":"Mater Today Bio"},{"issue":"46","key":"5563_CR128","doi-asserted-by":"publisher","first-page":"43374","DOI":"10.1021\/acsomega.3c04479","volume":"8","author":"L Huang","year":"2023","unstructured":"Huang L et al (2023) Research advances of engineered exosomes as drug delivery carrier. ACS Omega 8(46):43374\u201343387","journal-title":"ACS Omega"},{"key":"5563_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.impact.2020.100261","volume":"20","author":"S Fu","year":"2020","unstructured":"Fu S et al (2020) Exosome engineering: current progress in cargo loading and targeted delivery. NanoImpact 20:100261","journal-title":"NanoImpact"},{"issue":"7","key":"5563_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071711","volume":"10","author":"GL Nicolson","year":"2022","unstructured":"Nicolson GL, de Ferreira Mattos G (2022) Fifty years of the fluid\u2013mosaic model of biomembrane structure and organization and its importance in biomedicine with particular emphasis on membrane lipid replacement. Biomedicines 10(7):1711","journal-title":"Biomedicines"},{"issue":"1","key":"5563_CR131","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12951-021-00986-2","volume":"19","author":"Y-J Li","year":"2021","unstructured":"Li Y-J et al (2021) Artificial exosomes for translational nanomedicine. J Nanobiotechnology 19(1):242","journal-title":"J Nanobiotechnology"},{"key":"5563_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.939441","volume":"10","author":"A Liu","year":"2022","unstructured":"Liu A et al (2022) Research progress in membrane fusion-based hybrid exosomes for drug delivery systems. Front Bioeng Biotechnol 10:939441","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"5563_CR133","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1021\/acs.langmuir.7b02803","volume":"34","author":"S Ghazvini","year":"2018","unstructured":"Ghazvini S et al (2018) pH-induced changes in the surface viscosity of unsaturated phospholipids monitored using active interfacial microrheology. Langmuir 34(3):1159\u20131170","journal-title":"Langmuir"},{"key":"5563_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051358","author":"SA Akimov","year":"2018","unstructured":"Akimov SA et al (2018) Phosphatidylcholine membrane fusion is pH-dependent. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19051358","journal-title":"Int J Mol Sci"},{"issue":"11","key":"5563_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112256","volume":"14","author":"ER Gomes","year":"2022","unstructured":"Gomes ER, Souza FR, Cassali GD, Sabino AdP, Barros ALBd, Oliveira MC (2022) Investigation of the antitumor activity and toxicity of tumor-derived exosomes fused with long-circulating and pH-sensitive liposomes containing doxorubicin. Pharmaceutics 14(11):2256. https:\/\/doi.org\/10.3390\/pharmaceutics14112256","journal-title":"Pharmaceutics"},{"key":"5563_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216107","volume":"558","author":"C Ducrot","year":"2023","unstructured":"Ducrot C, Loiseau S, Wong C, Madec E, Volatron J, Piffoux M (2023) Hybrid extracellular vesicles for drug delivery. Cancer Lett 558:216107. https:\/\/doi.org\/10.1016\/j.canlet.2023.216107","journal-title":"Cancer Lett"},{"issue":"9","key":"5563_CR137","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/pharmaceutics12090849","volume":"12","author":"K Elkhoury","year":"2020","unstructured":"Elkhoury K et al (2020) Engineering smart targeting nanovesicles and their combination with hydrogels for controlled drug delivery. Pharmaceutics 12(9):849","journal-title":"Pharmaceutics"},{"issue":"1","key":"5563_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-018-0388-4","volume":"16","author":"TJ Antes","year":"2018","unstructured":"Antes TJ, Middleton RC, Luther KM, Ijichi T, Peck KA, Liu WJ, Valle J, Echavez AK, et al. (2018) Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display. J Nanobiotechnology 16(1):61. https:\/\/doi.org\/10.1186\/s12951-018-0388-4","journal-title":"J Nanobiotechnology"},{"key":"5563_CR139","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jare.2021.01.001","volume":"31","author":"N Parada","year":"2021","unstructured":"Parada N et al (2021) Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res 31:61\u201374","journal-title":"J Adv Res"},{"issue":"4","key":"5563_CR140","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s13770-021-00361-0","volume":"18","author":"H Choi","year":"2021","unstructured":"Choi H et al (2021) Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng Regen Med 18(4):499\u2013511","journal-title":"Tissue Eng Regen Med"},{"issue":"7","key":"5563_CR141","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y et al (2021) Engineering exosomes for targeted drug delivery. Theranostics 11(7):3183","journal-title":"Theranostics"},{"issue":"10","key":"5563_CR142","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1021\/bc500291r","volume":"25","author":"T Smyth","year":"2014","unstructured":"Smyth T et al (2014) Surface functionalization of exosomes using click chemistry. Bioconjug Chem 25(10):1777\u20131784","journal-title":"Bioconjug Chem"},{"issue":"17","key":"5563_CR143","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.3390\/ijms22179543","volume":"22","author":"N Ku\u010duk","year":"2021","unstructured":"Ku\u010duk N et al (2021) Exosomes engineering and their roles as therapy delivery tools, therapeutic targets, and biomarkers. Int J Mol Sci 22(17):9543","journal-title":"Int J Mol Sci"},{"issue":"21","key":"5563_CR144","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1039\/D0TB00744G","volume":"8","author":"S Rayamajhi","year":"2020","unstructured":"Rayamajhi S, Aryal S (2020) Surface functionalization strategies of extracellular vesicles. J Mater Chem B 8(21):4552\u20134569","journal-title":"J Mater Chem B"},{"key":"5563_CR145","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejpb.2019.08.009","volume":"144","author":"GE Melling","year":"2019","unstructured":"Melling GE et al (2019) The challenges and possibilities of extracellular vesicles as therapeutic vehicles. Eur J Pharm Biopharm 144:50\u201356","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"5563_CR146","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1021\/nn402232g","volume":"7","author":"SC Jang","year":"2013","unstructured":"Jang SC et al (2013) Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7(9):7698\u20137710","journal-title":"ACS Nano"},{"issue":"1","key":"5563_CR147","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1038\/s41467-019-11718-4","volume":"10","author":"T Yong","year":"2019","unstructured":"Yong T et al (2019) Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun 10(1):3838","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"5563_CR148","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijpharm.2017.02.005","volume":"520","author":"S Perteghella","year":"2017","unstructured":"Perteghella S et al (2017) Stem cell-extracellular vesicles as drug delivery systems: new frontiers for silk\/curcumin nanoparticles. Int J Pharm 520(1\u20132):86\u201397","journal-title":"Int J Pharm"},{"issue":"1","key":"5563_CR149","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1080\/10717544.2018.1513609","volume":"25","author":"M Millard","year":"2018","unstructured":"Millard M et al (2018) mTHPC-loaded extracellular vesicles outperform liposomal and free mTHPC formulations by an increased stability, drug delivery efficiency and cytotoxic effect in tridimensional model of tumors. Drug Deliv 25(1):1790\u20131801","journal-title":"Drug Deliv"},{"issue":"2","key":"5563_CR150","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1159\/000488635","volume":"46","author":"X Ma","year":"2018","unstructured":"Ma X et al (2018) Loading MiR-210 in endothelial progenitor cells derived exosomes boosts their beneficial effects on hypoxia\/reoxygeneation-injured human endothelial cells via protecting mitochondrial function. Cell Physiol Biochem 46(2):664\u2013675","journal-title":"Cell Physiol Biochem"},{"key":"5563_CR151","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.12659\/MSM.915727","volume":"25","author":"D Li","year":"2019","unstructured":"Li D et al (2019) Exosomes from MiR-21-5p-increased neurons play a role in neuroprotection by suppressing Rab11a-mediated neuronal autophagy in vitro after traumatic brain injury. Med Sci Monit 25:1871","journal-title":"Med Sci Monit"},{"key":"5563_CR152","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3389\/fonc.2019.00782","volume":"9","author":"H Monfared","year":"2019","unstructured":"Monfared H et al (2019) Potential therapeutic effects of exosomes packed with a miR-21-sponge construct in a rat model of glioblastoma. Front Oncol 9:782","journal-title":"Front Oncol"},{"issue":"8","key":"5563_CR153","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221679","volume":"14","author":"N Zeh","year":"2019","unstructured":"Zeh N et al (2019) Human CAP cells represent a novel source for functional, miRNA-loaded exosome production. PLoS One 14(8):e0221679","journal-title":"PLoS One"},{"issue":"4","key":"5563_CR154","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/nano7040077","volume":"7","author":"K Tatiparti","year":"2017","unstructured":"Tatiparti K et al (2017) SiRNA delivery strategies: a comprehensive review of recent developments. Nanomaterials 7(4):77","journal-title":"Nanomaterials"},{"issue":"2","key":"5563_CR155","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13365-015-0383-6","volume":"22","author":"MB Khan","year":"2016","unstructured":"Khan MB et al (2016) Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce A\u03b21\u201342 secretion in SH-SY5Y neural cells. J Neurovirol 22(2):179\u2013190","journal-title":"J Neurovirol"},{"issue":"3","key":"5563_CR156","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1158\/1535-7163.MCT-19-0928","volume":"19","author":"AV Forterre","year":"2020","unstructured":"Forterre AV et al (2020) Extracellular vesicle\u2013mediated in vitro transcribed mRNA delivery for treatment of HER2+ breast cancer xenografts in mice by prodrug CB1954 without general toxicity. Mol Cancer Ther 19(3):858\u2013867","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"5563_CR157","doi-asserted-by":"publisher","first-page":"E1433","DOI":"10.1073\/pnas.1418401112","volume":"112","author":"M Kanada","year":"2015","unstructured":"Kanada M et al (2015) Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci USA 112(12):E1433\u2013E1442","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"5563_CR158","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1158\/1535-7163.MCT-19-0299","volume":"18","author":"M Kanada","year":"2019","unstructured":"Kanada M et al (2019) Microvesicle-mediated delivery of minicircle DNA results in effective gene-directed enzyme prodrug cancer therapy. Mol Cancer Ther 18(12):2331\u20132342","journal-title":"Mol Cancer Ther"},{"key":"5563_CR159","doi-asserted-by":"crossref","unstructured":"Tran F, Boedicker JQ (2019)\u00a0Plasmid characteristics modulate the propensity of gene exchange in bacterial vesicles. J Bacteriol\u00a0201(7):00430\u201318","DOI":"10.1128\/JB.00430-18"},{"issue":"11","key":"5563_CR160","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/pharmaceutics12111120","volume":"12","author":"EM Rhea","year":"2020","unstructured":"Rhea EM et al (2020) Intranasal delivery: effects on the neuroimmune axes and treatment of neuroinflammation. Pharmaceutics 12(11):1120","journal-title":"Pharmaceutics"},{"key":"5563_CR161","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuroimage.2019.03.050","volume":"194","author":"SE Thanarajah","year":"2019","unstructured":"Thanarajah SE, Edwin Thanarajah S, Iglesias S, Kuzmanovic B, Rigoux L, Stephan KE, Br\u00fcning JC, Tittgemeyer M (2019) Modulation of midbrain neurocircuitry by intranasal insulin. Neuroimage 194:120\u2013127. https:\/\/doi.org\/10.1016\/j.neuroimage.2019.03.050","journal-title":"Neuroimage"},{"issue":"9","key":"5563_CR162","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","volume":"77","author":"S Craft","year":"2020","unstructured":"Craft S et al (2020) Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial. JAMA Neurol 77(9):1099\u20131109","journal-title":"JAMA Neurol"},{"issue":"12","key":"5563_CR163","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/stem.3456","volume":"39","author":"S Herman","year":"2021","unstructured":"Herman S, Fishel I, Offen D (2021) Intranasal delivery of mesenchymal stem cells-derived extracellular vesicles for the treatment of neurological diseases. Stem Cells 39(12):1589\u20131600","journal-title":"Stem Cells"},{"issue":"18","key":"5563_CR164","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","volume":"7","author":"P Arora","year":"2002","unstructured":"Arora P, Sharma S, Garg S (2002) Permeability issues in nasal drug delivery. Drug Discov Today 7(18):967\u2013975","journal-title":"Drug Discov Today"},{"issue":"1\u20132","key":"5563_CR165","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijpharm.2006.11.013","volume":"335","author":"AK Leonard","year":"2007","unstructured":"Leonard AK et al (2007) In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo. Int J Pharm 335(1\u20132):138\u2013146","journal-title":"Int J Pharm"},{"issue":"6","key":"5563_CR166","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nn0602-849","volume":"5","author":"J Born","year":"2002","unstructured":"Born J et al (2002) Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5(6):514\u2013516","journal-title":"Nat Neurosci"},{"issue":"2","key":"5563_CR167","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/pharmaceutics15020548","volume":"15","author":"AM Tolomeo","year":"2023","unstructured":"Tolomeo AM et al (2023) Biodistribution of intratracheal, intranasal, and intravenous injections of human mesenchymal stromal cell-derived extracellular vesicles in a mouse model for drug delivery studies. Pharmaceutics 15(2):548","journal-title":"Pharmaceutics"},{"key":"5563_CR168","doi-asserted-by":"publisher","unstructured":"Wu J, Li A, Shi Yu, Wang Y, Luo J, Zhuang W, Ma X, Qiao Z et al (2025) Intranasal delivery of mesenchymal stem cell-derived exosomes ameliorates experimental autoimmune encephalomyelitis. Int Immunopharmacol 146:113853. https:\/\/doi.org\/10.1016\/j.intimp.2024.113853","DOI":"10.1016\/j.intimp.2024.113853"},{"key":"5563_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115143","volume":"386","author":"S Gotoh","year":"2025","unstructured":"Gotoh S et al (2025) Intranasal administration of stem cell-derived exosome alleviates cognitive impairment against subarachnoid hemorrhage. Exp Neurol 386:115143","journal-title":"Exp Neurol"},{"issue":"11","key":"5563_CR170","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3390\/pharmaceutics15112578","volume":"15","author":"W Shen","year":"2023","unstructured":"Shen W et al (2023) Rapid and widespread distribution of intranasal small extracellular vesicles derived from mesenchymal stem cells throughout the brain potentially via the perivascular pathway. Pharmaceutics 15(11):2578","journal-title":"Pharmaceutics"},{"key":"5563_CR171","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"195","author":"TP Crowe","year":"2018","unstructured":"Crowe TP et al (2018) Mechanism of intranasal drug delivery directly to the brain. Life Sci 195:44\u201352","journal-title":"Life Sci"},{"issue":"4","key":"5563_CR172","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/pharmaceutics16040446","volume":"16","author":"T Ikeda","year":"2024","unstructured":"Ikeda T et al (2024) Intranasal administration of mesenchymal stem cell-derived exosome alleviates hypoxic-ischemic brain injury. Pharmaceutics 16(4):446","journal-title":"Pharmaceutics"},{"issue":"6","key":"5563_CR173","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1021\/acs.nanolett.8b04148","volume":"19","author":"N Perets","year":"2019","unstructured":"Perets N et al (2019) Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders. Nano Lett 19(6):3422\u20133431","journal-title":"Nano Lett"},{"issue":"9","key":"5563_CR174","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1021\/acsabm.0c00831","volume":"3","author":"Y Liang","year":"2020","unstructured":"Liang Y et al (2020) Mesenchymal stem cell-derived exosomes for treatment of autism spectrum disorder. ACS Appl Bio Mater 3(9):6384\u20136393","journal-title":"ACS Appl Bio Mater"},{"issue":"19","key":"5563_CR175","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1039\/D2BM00518B","volume":"10","author":"Y Zhai","year":"2022","unstructured":"Zhai Y et al (2022) High-efficiency brain-targeted intranasal delivery of BDNF mediated by engineered exosomes to promote remyelination. Biomater Sci 10(19):5707\u20135718","journal-title":"Biomater Sci"},{"issue":"2","key":"5563_CR176","first-page":"202","volume":"19","author":"Y Sun","year":"2020","unstructured":"Sun Y, Yang Z, Zhang W (2020) Recent advance in mesenchymal stem cell-derived exosomes in treatment of central nervous system diseases. Chin J Neuromed 19(2):202\u2013207","journal-title":"Chin J Neuromed"},{"issue":"12","key":"5563_CR177","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/cns.13743","volume":"27","author":"J Mattingly","year":"2021","unstructured":"Mattingly J et al (2021) The promise of exosome applications in treating central nervous system diseases. CNS Neurosci Ther 27(12):1437\u20131445","journal-title":"CNS Neurosci Ther"},{"key":"5563_CR178","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ace39c","author":"J Wang","year":"2023","unstructured":"Wang J, Yang L (2023) The role of exosomes in central nervous system tissue regeneration and repair. Biomed Mater. https:\/\/doi.org\/10.1088\/1748-605X\/ace39c","journal-title":"Biomed Mater"},{"issue":"3","key":"5563_CR179","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11060-013-1346-5","volume":"116","author":"A Peterson","year":"2014","unstructured":"Peterson A et al (2014) A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option. J Neuro-Oncol 116(3):437\u2013446","journal-title":"J Neuro-Oncol"},{"key":"5563_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2025.104004","author":"S Rai","year":"2025","unstructured":"Rai S et al (2025) Exosome-based therapeutics: advancing drug delivery for neurodegenerative diseases. Mol Cell Neurosci. https:\/\/doi.org\/10.1016\/j.mcn.2025.104004","journal-title":"Mol Cell Neurosci"},{"key":"5563_CR181","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02005-y","author":"Y Hu","year":"2023","unstructured":"Hu Y et al (2023) Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression. J Nanobiotechnology. https:\/\/doi.org\/10.1186\/s12951-023-02005-y","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"5563_CR182","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/mp.2015.166","volume":"21","author":"DS Quintana","year":"2016","unstructured":"Quintana DS et al (2016) The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders. Mol Psychiatry 21(1):29\u201338","journal-title":"Mol Psychiatry"},{"issue":"4","key":"5563_CR183","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI et al (2024) Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med 56(4):836\u2013849","journal-title":"Exp Mol Med"},{"key":"5563_CR184","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ad3310","author":"W Yin","year":"2024","unstructured":"Yin W et al (2024) Targeted exosome-based nanoplatform for new-generation therapeutic strategies. Biomed Mater. https:\/\/doi.org\/10.1088\/1748-605X\/ad3310","journal-title":"Biomed Mater"},{"key":"5563_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082042","author":"HB Koh","year":"2023","unstructured":"Koh HB et al (2023) Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15082042","journal-title":"Pharmaceutics"},{"key":"5563_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03352-8","author":"S Mehdizadeh","year":"2025","unstructured":"Mehdizadeh S et al (2025) Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. J Nanobiotechnology. https:\/\/doi.org\/10.1186\/s12951-025-03352-8","journal-title":"J Nanobiotechnology"},{"key":"5563_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2023.108647","author":"L Zheng","year":"2024","unstructured":"Zheng L et al (2024) Recent progresses of exosome\u2013liposome fusions in drug delivery. Chin Chem Lett. https:\/\/doi.org\/10.1016\/j.cclet.2023.108647","journal-title":"Chin Chem Lett"},{"key":"5563_CR188","doi-asserted-by":"publisher","unstructured":"Deshmukh PK et al (2021) Vesicular carriers for direct nose-to-brain drug delivery. In: Direct nose-to-brain drug delivery: mechanism, technological advances, applications, and regulatory updates. p. 209\u2013223. https:\/\/doi.org\/10.1016\/B978-0-12-822522-6.00010-2","DOI":"10.1016\/B978-0-12-822522-6.00010-2"},{"key":"5563_CR189","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13071079","author":"A Maaz","year":"2021","unstructured":"Maaz A, Blagbrough IS, De Bank PA (2021) In vitro evaluation of nasal aerosol depositions: an insight for direct nose to brain drug delivery. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13071079","journal-title":"Pharmaceutics"},{"key":"5563_CR190","doi-asserted-by":"publisher","unstructured":"Dhas N et al (2021) Direct transport theory: from the nose to the brain, in Direct nose-to-brain drug delivery: mechanism, technological advances, applications, and regulatory updates. p. 15\u201337. https:\/\/doi.org\/10.1016\/B978-0-12-822522-6.00001-1","DOI":"10.1016\/B978-0-12-822522-6.00001-1"},{"issue":"14","key":"5563_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21145016","volume":"21","author":"R Popescu","year":"2020","unstructured":"Popescu R et al (2020) New opportunity to formulate intranasal vaccines and drug delivery systems based on chitosan. Int J Mol Sci 21(14):1\u201323","journal-title":"Int J Mol Sci"},{"key":"5563_CR192","doi-asserted-by":"publisher","DOI":"10.3390\/md15120370","author":"MM Silva","year":"2017","unstructured":"Silva MM et al (2017) Chitosan nanoparticles as a mucoadhesive drug delivery system for ocular administration. Mar Drugs. https:\/\/doi.org\/10.3390\/md15120370","journal-title":"Mar Drugs"},{"key":"5563_CR193","doi-asserted-by":"publisher","unstructured":"Fukakusa S et al (2024) Brain drug delivery from the nasal olfactory region is enhanced using lauroylcholine chloride: an estimation using in vivo PET imaging. Nuclear Med Biol 138\u2013139. https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108968","DOI":"10.1016\/j.nucmedbio.2024.108968"},{"key":"5563_CR194","unstructured":"Erikson A et al\u00a0(2008) The impact of enzymatic degradation on the uptake of differently sized therapeutic molecules. Anticancer Res\u00a028(6 A):3557\u20133566"},{"issue":"2","key":"5563_CR195","first-page":"P349","volume":"3","author":"PG Subhash","year":"2012","unstructured":"Subhash PG, Dinesh BM, Ravikumar M (2012) Assessment of lercanidipine hydrochloride for transdermal delivery: physicochemical, in-vitro and ex-vivo characterization of matrix type lercanidipine hydrochloride transdermal patches. Int J Pharma Bio Sci 3(2):P349\u2013P365","journal-title":"Int J Pharma Bio Sci"},{"issue":"1","key":"5563_CR196","first-page":"66","volume":"17","author":"SS Sangolkar","year":"2012","unstructured":"Sangolkar SS et al (2012) Particle size determination of nasal drug delivery system: a review. Int J Pharm Sci Rev Res 17(1):66\u201373","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"6","key":"5563_CR197","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1248\/bpb.b18-00133","volume":"41","author":"T Yamashita","year":"2018","unstructured":"Yamashita T, Takahashi Y, Takakura Y (2018) Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application. Biol Pharm Bull 41(6):835\u2013842","journal-title":"Biol Pharm Bull"},{"key":"5563_CR198","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.25011","author":"DK Jeppesen","year":"2014","unstructured":"Jeppesen DK et al (2014) Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J Extracell Vesicles. https:\/\/doi.org\/10.3402\/jev.v3.25011","journal-title":"J Extracell Vesicles"},{"key":"5563_CR199","doi-asserted-by":"publisher","unstructured":"Sanz-Rubio D et al (2018) Stability of circulating exosomal miRNAs in healthy subjects. Sci Rep 8(1). https:\/\/doi.org\/10.1038\/s41598-018-28748-5","DOI":"10.1038\/s41598-018-28748-5"},{"key":"5563_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.impact.2020.100261","author":"S Fu","year":"2020","unstructured":"Fu S et al (2020) Exosome engineering: current progress in cargo loading and targeted delivery. NanoImpact. https:\/\/doi.org\/10.1016\/j.impact.2020.100261","journal-title":"NanoImpact"},{"key":"5563_CR201","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101416","author":"H Zeng","year":"2023","unstructured":"Zeng H et al (2023) Current strategies for exosome cargo loading and targeting delivery. Cells. https:\/\/doi.org\/10.3390\/cells12101416","journal-title":"Cells"},{"key":"5563_CR202","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01219-2","author":"A Raghav","year":"2021","unstructured":"Raghav A, Jeong GB (2021) A systematic review on the modifications of extracellular vesicles: a revolutionized tool of nano-biotechnology. J Nanobiotechnology. https:\/\/doi.org\/10.1186\/s12951-021-01219-2","journal-title":"J Nanobiotechnology"},{"issue":"7","key":"5563_CR203","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1021\/acs.molpharmaceut.5c00386","volume":"22","author":"S Kumar","year":"2025","unstructured":"Kumar S et al (2025) Intranasal therapeutics for neurodegenerative disorders: overcoming the blood-brain barrier with smart formulations and devices. Mol Pharm 22(7):3602\u20133620","journal-title":"Mol Pharm"},{"key":"5563_CR204","doi-asserted-by":"publisher","DOI":"10.1155\/jnt\/7697122","author":"FV Borbolla-Jim\u00e9nez","year":"2025","unstructured":"Borbolla-Jim\u00e9nez FV et al (2025) Nanoparticles navigating the intranasal route: innovative approaches in neurodegenerative diseases. J Nanotechnol. https:\/\/doi.org\/10.1155\/jnt\/7697122","journal-title":"J Nanotechnol"},{"key":"5563_CR205","doi-asserted-by":"publisher","unstructured":"Dagdag O et al (2025) Surface functionalization of polymer-based nanomaterials. In: Surface-functionalized nanomaterials: environmental, energy storage, energy conversion applications. p. 87\u2013102 . https:\/\/doi.org\/10.1515\/9783111381800-006","DOI":"10.1515\/9783111381800-006"},{"key":"5563_CR206","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jconrel.2022.04.044","volume":"349","author":"CJ Gil","year":"2022","unstructured":"Gil CJ et al (2022) Tissue engineered drug delivery vehicles: methods to monitor and regulate the release behavior. J Control Release 349:143\u2013155","journal-title":"J Control Release"},{"key":"5563_CR207","doi-asserted-by":"publisher","unstructured":"Andriolo G et al (2023) Methodologies for scalable production of high-quality purified small extracellular vesicles from conditioned medium. In: Methods in molecular biology. vol 2668. Humana, New York, NY. p. 69\u201398. https:\/\/doi.org\/10.1007\/978-1-0716-3203-1_7","DOI":"10.1007\/978-1-0716-3203-1_7"},{"key":"5563_CR208","doi-asserted-by":"publisher","unstructured":"Yuan R et al (2023) Extracellular vesicle isolation by a tangential-flow filtration-based large-scale purification method. In: Methods in molecular biology, vol 2668. Humana, New York, NY. p. 45\u201355. https:\/\/doi.org\/10.1007\/978-1-0716-3203-1_5","DOI":"10.1007\/978-1-0716-3203-1_5"},{"issue":"3","key":"5563_CR209","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.apsb.2023.10.004","volume":"14","author":"Y Wan","year":"2024","unstructured":"Wan Y et al (2024) Engineered extracellular vesicles efficiently deliver CRISPR-Cas9 ribonucleoprotein (RNP) to inhibit herpes simplex virus1 infection in vitro and in vivo. Acta Pharm Sin B 14(3):1362\u20131379","journal-title":"Acta Pharm Sin B"},{"key":"5563_CR210","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jconrel.2025.01.090","volume":"380","author":"P Xiao","year":"2025","unstructured":"Xiao P et al (2025) Modulating the elasticity of milk exosome-based hybrid vesicles to optimize transepithelial transport and enhance oral peptide delivery. J Control Release 380:36\u201351","journal-title":"J Control Release"},{"issue":"4","key":"5563_CR211","first-page":"1172","volume":"57","author":"XF Zhou","year":"2022","unstructured":"Zhou XF et al (2022) Comparative study on two different preparation methods and characterization of pancreatic cancer cell-derived hybrid exosome. Yaoxue Xuebao 57(4):1172\u20131179","journal-title":"Yaoxue Xuebao"},{"key":"5563_CR212","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073137","author":"EC Lee","year":"2025","unstructured":"Lee EC et al (2025) Engineering exosomes for CNS disorders: advances, challenges, and therapeutic potential. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26073137","journal-title":"Int J Mol Sci"},{"key":"5563_CR213","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.70215","author":"M Kudpaje","year":"2025","unstructured":"Kudpaje M, Joghee S, Ram\u00a0Kumar R (2025) Exosomes as a nanotheranostic platform in brain diseases. Eur J Neurosci. https:\/\/doi.org\/10.1111\/ejn.70215","journal-title":"Eur J Neurosci"},{"key":"5563_CR214","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051439","author":"DI Avgoulas","year":"2023","unstructured":"Avgoulas DI et al (2023) Therapeutic and diagnostic potential of exosomes as drug delivery systems in brain cancer. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15051439","journal-title":"Pharmaceutics"},{"issue":"10","key":"5563_CR215","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1039\/D3BM01055D","volume":"12","author":"Z Zakeri","year":"2024","unstructured":"Zakeri Z et al (2024) Exosomes encapsulated in hydrogels for effective central nervous system drug delivery. Biomater Sci 12(10):2561\u20132578","journal-title":"Biomater Sci"},{"key":"5563_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2021.101678","author":"B Liu","year":"2022","unstructured":"Liu B et al (2022) Bone marrow mesenchymal stem cell derived exosomal miR-455-5p protects against spinal cord ischemia reperfusion injury. Tissue Cell. https:\/\/doi.org\/10.1016\/j.tice.2021.101678","journal-title":"Tissue Cell"},{"issue":"2","key":"5563_CR217","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/nep3.30","volume":"1","author":"A Waseem","year":"2023","unstructured":"Waseem A et al (2023) Mesenchymal stem cell-derived exosomes: shaping the next era of stroke treatment. Neuroprotection 1(2):99\u2013116","journal-title":"Neuroprotection"},{"key":"5563_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124921","author":"M Jos\u00e9 S\u00e1nchez","year":"2024","unstructured":"Jos\u00e9 S\u00e1nchez M et al (2024) Enhanced quantification and cell tracking of dual fluorescent labeled extracellular vesicles. Int J Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124921","journal-title":"Int J Pharm"},{"key":"5563_CR219","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123473","author":"M Dlugolecka","year":"2021","unstructured":"Dlugolecka M et al (2021) Characterization of extracellular vesicles from bronchoalveolar lavage fluid and plasma of patients with lung lesions using fluorescence nanoparticle tracking analysis. Cells. https:\/\/doi.org\/10.3390\/cells10123473","journal-title":"Cells"},{"issue":"4","key":"5563_CR220","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12033-021-00300-3","volume":"63","author":"TK Kurian","year":"2021","unstructured":"Kurian TK et al (2021) Elucidating methods for isolation and quantification of exosomes: a review. Mol Biotechnol 63(4):249\u2013266","journal-title":"Mol Biotechnol"},{"key":"5563_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120152","author":"J Wang","year":"2020","unstructured":"Wang J et al (2020) Loading of metal isotope-containing intercalators for mass cytometry-based high-throughput quantitation of exosome uptake at the single-cell level. Biomaterials. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120152","journal-title":"Biomaterials"},{"key":"5563_CR222","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jconrel.2023.10.003","volume":"363","author":"K Haroon","year":"2023","unstructured":"Haroon K et al (2023) Bio-clickable, small extracellular vesicles-COCKTAIL therapy for ischemic stroke. J Control Release 363:585\u2013596","journal-title":"J Control Release"},{"issue":"8","key":"5563_CR223","doi-asserted-by":"publisher","first-page":"340","DOI":"10.5483\/BMBRep.2025-0060","volume":"58","author":"S Hong","year":"2025","unstructured":"Hong S et al (2025) In vivo exosome imaging: applications of diverse visualization techniques. BMB Rep 58(8):340\u2013349","journal-title":"BMB Rep"},{"key":"5563_CR224","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12241","author":"DR Arifin","year":"2022","unstructured":"Arifin DR, Witwer KW, Bulte JWM (2022) Non-invasive imaging of extracellular vesicles: quo vaditis in vivo? J Extracell Vesicles. https:\/\/doi.org\/10.1002\/jev2.12241","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"5563_CR225","first-page":"301","volume":"50","author":"W Yang","year":"2025","unstructured":"Yang W, Tan S, Zuo C (2025) Exosome tracking by magnetic resonance imaging. Journal of Central South University (Medical Sciences) 50(2):301\u2013312","journal-title":"J Central South Univ (Medical Sciences)"},{"key":"5563_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiomech.2024.106231","author":"RM Sicard","year":"2024","unstructured":"Sicard RM, Frank-Ito DO (2024) Parameter characteristics in intranasal drug delivery: a key to targeting medications to the olfactory airspace. Clin Biomech. https:\/\/doi.org\/10.1016\/j.clinbiomech.2024.106231","journal-title":"Clin Biomech"},{"key":"5563_CR227","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jaerosci.2018.05.010","volume":"123","author":"Y Feng","year":"2018","unstructured":"Feng Y et al (2018) An in silico inter-subject variability study of extra-thoracic morphology effects on inhaled particle transport and deposition. J Aerosol Sci 123:185\u2013207","journal-title":"J Aerosol Sci"},{"key":"5563_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmultiphaseflow.2021.103842","author":"MM Rahman","year":"2021","unstructured":"Rahman MM et al (2021) Numerical study of nanoscale and microscale particle transport in realistic lung models with and without stenosis. Int J Multiphase Flow. https:\/\/doi.org\/10.1016\/j.ijmultiphaseflow.2021.103842","journal-title":"Int J Multiphase Flow"},{"key":"5563_CR229","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.27031","author":"RJ Lobb","year":"2015","unstructured":"Lobb RJ et al (2015) Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. https:\/\/doi.org\/10.3402\/jev.v4.27031","journal-title":"J Extracell Vesicles"},{"issue":"7","key":"5563_CR230","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00216-022-04174-5","volume":"415","author":"TS Martins","year":"2023","unstructured":"Martins TS, Vaz M, Henriques AG (2023) A review on comparative studies addressing exosome isolation methods from body fluids. Anal Bioanal Chem 415(7):1239\u20131263","journal-title":"Anal Bioanal Chem"},{"key":"5563_CR231","doi-asserted-by":"publisher","unstructured":"Mehdiani A et al (2015) An innovative method for exosome quantification and size measurement. J Visualized Exp (95):50974. https:\/\/doi.org\/10.3791\/50974","DOI":"10.3791\/50974"},{"issue":"7","key":"5563_CR232","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1021\/acsnano.1c02556","volume":"15","author":"S Cho","year":"2021","unstructured":"Cho S et al (2021) Multifluorescence single extracellular vesicle analysis by time-sequential illumination and tracking. ACS Nano 15(7):11753\u201311761","journal-title":"ACS Nano"},{"issue":"9","key":"5563_CR233","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2174\/011574888X311270240319084835","volume":"19","author":"F Zhang","year":"2024","unstructured":"Zhang F, Zhang L, Yu H (2024) Potential druggability of mesenchymal stem\/stromal cell-derived exosomes. Curr Stem Cell Res Ther 19(9):1195\u20131209","journal-title":"Curr Stem Cell Res Ther"},{"key":"5563_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117248","author":"F Soltanmohammadi","year":"2024","unstructured":"Soltanmohammadi F et al (2024) Current knowledge of hybrid nanoplatforms composed of exosomes and organic\/inorganic nanoparticles for disease treatment and cell\/tissue imaging. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2024.117248","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"5563_CR235","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1021\/acs.chemmater.2c03705","volume":"35","author":"A Nair","year":"2023","unstructured":"Nair A et al (2023) Hybrid nanoparticle system integrating tumor-derived exosomes and poly(amidoamine) dendrimers: implications for an effective gene delivery platform. Chem Mater 35(8):3138\u20133150","journal-title":"Chem Mater"},{"key":"5563_CR236","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201707360","author":"J Wang","year":"2018","unstructured":"Wang J et al (2018) Designer exosomes for active targeted chemo-photothermal synergistic tumor therapy. Adv Funct Mater. https:\/\/doi.org\/10.1002\/adfm.201707360","journal-title":"Adv Funct Mater"},{"key":"5563_CR237","doi-asserted-by":"publisher","unstructured":"Piffoux M et al (2022) Generation of hybrid extracellular vesicles by fusion with functionalized liposomes. In: Methods in molecular Biology, vol 2473. Humana, New York, NY. p. 385\u2013396. https:\/\/doi.org\/10.1007\/978-1-0716-2209-4_24","DOI":"10.1007\/978-1-0716-2209-4_24"},{"key":"5563_CR238","unstructured":"Hao R et al (2022) A microfluidic device to promote exosome secretion. In: MicroTAS 2022 - 26th International conference on miniaturized systems for chemistry and life sciences.\u00a023\u201327 October 2022, Hangzhou, China"},{"key":"5563_CR239","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1550447","author":"L Zhang","year":"2025","unstructured":"Zhang L et al (2025) Mesenchymal stem cell-derived exosome subpopulations remained consistent for 28 culture days, displaying therapeutic effects in a silicosis mouse model. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2025.1550447","journal-title":"Front Cell Dev Biol"},{"key":"5563_CR240","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1635151","author":"JP Gurney","year":"2025","unstructured":"Gurney JP et al (2025) Modulation of ASC-derived extracellular vesicles containing cargo that specifically enhances wound healing. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1635151","journal-title":"Front Pharmacol"},{"key":"5563_CR241","doi-asserted-by":"publisher","unstructured":"Ludlow JW, Buehrer BM (2024) Analyses and utilization of selectively tuned human adipose-derived stromal\/stem cell exosomes. In: Methods in molecular biology. pp 309\u2013322.\u00a0https:\/\/doi.org\/10.1007\/978-1-0716-3762-3_22","DOI":"10.1007\/978-1-0716-3762-3_22"},{"key":"5563_CR242","unstructured":"Kimura N et al (2021) Microfluidic methodologies for production of small-sized various artificial exosomes. In: MicroTAS 2021 - Palm Springs, Virtual, United States - 25th International Conference on Miniaturized Systems for Chemistry and Life Sciences."},{"key":"5563_CR243","doi-asserted-by":"publisher","unstructured":"Le MCN, Fan ZH (2021) Exosome isolation using nanostructures and microfluidic devices. Biomed Materials (Bristol) 16(2). https:\/\/doi.org\/10.1088\/1748-605X\/abde70","DOI":"10.1088\/1748-605X\/abde70"},{"key":"5563_CR244","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17060940","author":"E Youssef","year":"2025","unstructured":"Youssef E et al (2025) Exosomes in precision oncology and beyond: from bench to bedside in diagnostics and therapeutics. Cancers. https:\/\/doi.org\/10.3390\/cancers17060940","journal-title":"Cancers"},{"issue":"3","key":"5563_CR245","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jcyt.2013.08.003","volume":"16","author":"KF Pearce","year":"2014","unstructured":"Pearce KF et al (2014) Regulation of advanced therapy medicinal products in Europe and the role of academia. Cytotherapy 16(3):289\u2013297","journal-title":"Cytotherapy"},{"key":"5563_CR246","doi-asserted-by":"publisher","unstructured":"Bapat AA, Kalodimou VE, Muthu S (2025) Regulatory concerns for exosome- and other extracellular vesicle-based diagnostics and medicine products. In: Extracellular vesicles for therapeutic and diagnostic applications. p. 523\u2013536. https:\/\/doi.org\/10.1016\/B978-0-443-23891-8.00014-7","DOI":"10.1016\/B978-0-443-23891-8.00014-7"},{"key":"5563_CR247","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2025.114243","author":"K Deng","year":"2025","unstructured":"Deng K et al (2025) Harnessing engineered exosomes for transformative therapy of cardiovascular and cerebrovascular disorders: opportunities and challenges. Mater Des. https:\/\/doi.org\/10.1016\/j.matdes.2025.114243","journal-title":"Mater Des"},{"key":"5563_CR248","doi-asserted-by":"publisher","unstructured":"Huanjin L et al (2025) Intranasal immunotherapy with allergen-loaded extracellular vesicles from mast cells alleviates allergic asthma inflammation in a murine model. Inflammation. https:\/\/doi.org\/10.1007\/s10753-025-02307-3","DOI":"10.1007\/s10753-025-02307-3"},{"key":"5563_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2023.100665","author":"N Tang","year":"2024","unstructured":"Tang N (2024) Exosomes in multiple sclerosis and Alzheimer\u2019s disease \u2013 adversary and ally. Biomed J. https:\/\/doi.org\/10.1016\/j.bj.2023.100665","journal-title":"Biomed J"},{"key":"5563_CR250","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.2147\/IJN.S454438","volume":"19","author":"XM Hu","year":"2024","unstructured":"Hu XM et al (2024) Non-clinical safety evaluation of exosomes derived from human umbilical cord mesenchymal stem cells in cynomolgus monkeys. Int J Nanomedicine 19:4923\u20134939","journal-title":"Int J Nanomedicine"},{"key":"5563_CR251","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2025.2541789","author":"Y Li","year":"2025","unstructured":"Li Y et al (2025) Prospects of engineered exosomes in clinical applications: a review. Drug Dev Ind Pharm. https:\/\/doi.org\/10.1080\/03639045.2025.2541789","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"5563_CR252","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00401-018-1868-1","volume":"136","author":"M Sardar Sinha","year":"2018","unstructured":"Sardar Sinha M et al (2018) Alzheimer\u2019s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol 136(1):41\u201356","journal-title":"Acta Neuropathol"},{"key":"5563_CR253","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123548","author":"Y Zhu","year":"2026","unstructured":"Zhu Y et al (2026) Recent advances in exosome-based nanodelivery systems for Parkinson\u2019s disease. Biomaterials. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123548","journal-title":"Biomaterials"},{"issue":"14","key":"5563_CR254","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1039\/D4BM00558A","volume":"12","author":"X Fan","year":"2024","unstructured":"Fan X et al (2024) A comprehensive review of engineered exosomes from the preparation strategy to therapeutic applications. Biomater Sci 12(14):3500\u20133521","journal-title":"Biomater Sci"},{"key":"5563_CR255","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02312-w","author":"G Xu","year":"2025","unstructured":"Xu G et al (2025) Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-025-02312-w","journal-title":"Signal Transduct Target Ther"},{"key":"5563_CR256","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2017.03.020","volume":"648","author":"AV Leonard","year":"2017","unstructured":"Leonard AV et al (2017) Localization of the corticospinal tract within the porcine spinal cord: implications for experimental modeling of traumatic spinal cord injury. Neurosci Lett 648:1\u20137","journal-title":"Neurosci Lett"},{"issue":"3","key":"5563_CR257","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s13311-017-0589-9","volume":"15","author":"M Le Corre","year":"2018","unstructured":"Le Corre M et al (2018) A novel translational model of spinal cord injury in nonhuman primate. Neurotherapeutics 15(3):751\u2013769","journal-title":"Neurotherapeutics"},{"key":"5563_CR258","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-025-00814-z","author":"A Pierre","year":"2025","unstructured":"Pierre A et al (2025) Can patient-derived in vitro models improve clinical translation in critical care research when used before animal studies? Intensive Care Med Exp. https:\/\/doi.org\/10.1186\/s40635-025-00814-z","journal-title":"Intensive Care Med Exp"},{"key":"5563_CR259","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02215-4","author":"J Li","year":"2025","unstructured":"Li J, Wang J, Chen Z (2025) Emerging role of exosomes in cancer therapy: progress and challenges. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-024-02215-4","journal-title":"Mol Cancer"},{"key":"5563_CR260","doi-asserted-by":"publisher","DOI":"10.3389\/fmedt.2025.1655471","author":"H Onohuean","year":"2025","unstructured":"Onohuean H et al (2025) Exosome engineering for targeted therapy of brain-infecting pathogens: molecular tools, delivery platforms, and translational advances. Frontiers in Medical Technology. https:\/\/doi.org\/10.3389\/fmedt.2025.1655471","journal-title":"Front Med Technol"},{"issue":"3","key":"5563_CR261","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s12013-025-01730-5","volume":"83","author":"TC Jangam","year":"2025","unstructured":"Jangam TC et al (2025) Exosomes as therapeutic and diagnostic tools: advances, challenges, and future directions. Cell Biochem Biophys 83(3):2805\u20132829","journal-title":"Cell Biochem Biophys"},{"key":"5563_CR262","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05247-z","author":"M Nikanfar","year":"2025","unstructured":"Nikanfar M et al (2025) Brain-derived exosomes in neurodevelopmental and neuropsychiatric disorders: molecular insights, therapeutic potential, and translational challenges. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05247-z","journal-title":"Mol Neurobiol"},{"key":"5563_CR263","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157405","author":"T Honda","year":"2025","unstructured":"Honda T, Kawabori M, Fujimura M (2025) Intra-arterial administration of stem cells and exosomes for central nervous system disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26157405","journal-title":"Int J Mol Sci"},{"key":"5563_CR264","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115286","author":"N Poondla","year":"2025","unstructured":"Poondla N et al (2025) Exosome-based therapies and biomarkers in stroke: current advances and future directions. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2025.115286","journal-title":"Exp Neurol"},{"key":"5563_CR265","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061118","author":"H Choi","year":"2022","unstructured":"Choi H et al (2022) Quantitative biodistribution and pharmacokinetics study of GMP-grade exosomes labeled with89Zr radioisotope in mice and rats. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14061118","journal-title":"Pharmaceutics"},{"key":"5563_CR266","doi-asserted-by":"publisher","unstructured":"Yadav K et al (2025) Unlocking exosome therapeutics: the critical role of pharmacokinetics in clinical applications. Tissue Cell 93. https:\/\/doi.org\/10.1016\/j.tice.2025.102749","DOI":"10.1016\/j.tice.2025.102749"},{"key":"5563_CR267","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11120649","author":"DH Kim","year":"2019","unstructured":"Kim DH et al (2019) Noninvasive assessment of exosome pharmacokinetics in vivo: a review. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics11120649","journal-title":"Pharmaceutics"},{"key":"5563_CR268","doi-asserted-by":"publisher","unstructured":"Singh S, Arshid N, Cinti S (2022) Electrochemical nano biosensors for the detection of extracellular vesicles exosomes: from the benchtop to everywhere? Biosens Bioelectron 216. https:\/\/doi.org\/10.1016\/j.bios.2022.114635","DOI":"10.1016\/j.bios.2022.114635"},{"key":"5563_CR269","doi-asserted-by":"publisher","DOI":"10.1016\/j.snb.2024.135614","author":"J Chen","year":"2024","unstructured":"Chen J et al (2024) Accurate and portable tumor exosomes detection based on manganese dioxide and aptamer-functionalized fluorescent microspheres mediated dual-mode lateral flow assay. Sensors and Actuators B: Chemical. https:\/\/doi.org\/10.1016\/j.snb.2024.135614","journal-title":"Sensors and Actuators B: Chemical"},{"issue":"7","key":"5563_CR270","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1021\/acs.analchem.1c04910","volume":"94","author":"J Su","year":"2022","unstructured":"Su J et al (2022) Smartphone-based electrochemical biosensors for directly detecting serum-derived exosomes and monitoring their secretion. Anal Chem 94(7):3235\u20133244","journal-title":"Anal Chem"},{"key":"5563_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125584","author":"S Wei","year":"2025","unstructured":"Wei S et al (2025) The review of nasal drug delivery system: the strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption. Int J Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125584","journal-title":"Int J Pharm"},{"issue":"5","key":"5563_CR272","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/jamp.2019.1549","volume":"33","author":"SB Yarragudi","year":"2020","unstructured":"Yarragudi SB et al (2020) Olfactory targeting of microparticles through inhalation and bi-directional airflow: effect of particle size and nasal anatomy. J Aerosol Med Pulm Drug Deliv 33(5):258\u2013270","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"5563_CR273","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123809","author":"H Guo","year":"2024","unstructured":"Guo H et al (2024) Rivastigmine nasal spray for the treatment of Alzheimer\u2019s disease: olfactory deposition and brain delivery. Int J Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123809","journal-title":"Int J Pharm"},{"key":"5563_CR274","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ddtec.2016.07.002","volume":"20","author":"GJ Schenk","year":"2016","unstructured":"Schenk GJ, de Vries HE (2016) Altered blood\u2013brain barrier transport in neuro-inflammatory disorders. Drug Discov Today Technol 20:5\u201311","journal-title":"Drug Discov Today Technol"},{"key":"5563_CR275","doi-asserted-by":"publisher","unstructured":"D\u2019Souza AA et al (2025) Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery. Exp Opin Drug Deliv. 2:1-20. https:\/\/doi.org\/10.1080\/17425247.2025.2568093","DOI":"10.1080\/17425247.2025.2568093"},{"issue":"2","key":"5563_CR276","first-page":"87","volume":"21","author":"M Hosseini","year":"2021","unstructured":"Hosseini M et al (2021) The therapeutic applications of exosomes in different types of diseases: a review. Curr Mol Med 21(2):87\u201395","journal-title":"Curr Mol Med"},{"key":"5563_CR277","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1051380","author":"G Liu","year":"2022","unstructured":"Liu G et al (2022) The potential therapeutic value and application prospect of engineered exosomes in human diseases. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2022.1051380","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"5563_CR278","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1021\/acs.bioconjchem.4c00414","volume":"35","author":"J Wang","year":"2024","unstructured":"Wang J et al (2024) Drug delivery targeting neuroinflammation to treat brain diseases. Bioconjug Chem 35(11):1687\u20131698","journal-title":"Bioconjug Chem"},{"issue":"6","key":"5563_CR279","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1042\/ETLS20210246","volume":"5","author":"RW Pettit","year":"2021","unstructured":"Pettit RW et al (2021) Artificial intelligence, machine learning, and deep learning for clinical outcome prediction. Emerg Top Life Sci 5(6):729\u2013745","journal-title":"Emerg Top Life Sci"},{"key":"5563_CR280","doi-asserted-by":"publisher","unstructured":"Gupta Y, Srivastava V, Singh RK (2025) AI-enhanced patient-centric clinical trial design. In: AIP Conference Proceedings. 3254 (1): 020020. https:\/\/doi.org\/10.1063\/5.0247858","DOI":"10.1063\/5.0247858"},{"key":"5563_CR281","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115143","author":"S Gotoh","year":"2025","unstructured":"Gotoh S et al (2025) Intranasal administration of stem cell-derived exosome alleviates cognitive impairment against subarachnoid hemorrhage. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2025.115143","journal-title":"Exp Neurol"},{"issue":"4","key":"5563_CR282","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1021\/acs.bioconjchem.9b00085","volume":"30","author":"M Zheng","year":"2019","unstructured":"Zheng M et al (2019) Harnessing exosomes for the development of brain drug delivery systems. Bioconjug Chem 30(4):994\u20131005","journal-title":"Bioconjug Chem"},{"key":"5563_CR283","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102252","author":"K Sun","year":"2022","unstructured":"Sun K et al (2022) Exosomes as CNS drug delivery tools and their applications. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14102252","journal-title":"Pharmaceutics"},{"issue":"6","key":"5563_CR284","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.clinthera.2014.05.005","volume":"36","author":"I Tsilioni","year":"2014","unstructured":"Tsilioni I, Panagiotidou S, Theoharides TC (2014) Exosomes in neurologic and psychiatric disorders. Clin Ther 36(6):882\u2013888","journal-title":"Clin Ther"},{"issue":"1","key":"5563_CR285","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12967-022-03493-6","volume":"20","author":"Y Fan","year":"2022","unstructured":"Fan Y, Chen Z, Zhang M (2022) Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases. J Transl Med 20(1):291","journal-title":"J Transl Med"},{"issue":"12","key":"5563_CR286","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1517\/17425247.2011.633508","volume":"8","author":"X Liu","year":"2011","unstructured":"Liu X (2011) Clinical trials of intranasal delivery for treating neurological disorders a critical review. Expert Opin Drug Deliv 8(12):1681\u20131690","journal-title":"Expert Opin Drug Deliv"},{"issue":"8","key":"5563_CR287","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1016\/j.apsb.2022.04.001","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: combining with intranasal delivery. Acta Pharm Sin B 12(8):3215\u20133232","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"5563_CR288","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12111120","volume":"12","author":"EM Rhea","year":"2020","unstructured":"Rhea EM et al (2020) Intranasal delivery: effects on the neuroimmune axes and treatment of neuroinflammation. Pharmaceutics 12(11):1\u201326","journal-title":"Pharmaceutics"},{"issue":"4","key":"5563_CR289","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s10555-022-10030-w","volume":"41","author":"A Quesnel","year":"2022","unstructured":"Quesnel A et al (2022) Message in the bottle: regulation of the tumor microenvironment via exosome-driven proteolysis. Cancer Metastasis Rev 41(4):789\u2013801","journal-title":"Cancer Metastasis Rev"},{"issue":"35","key":"5563_CR290","doi-asserted-by":"publisher","first-page":"37151","DOI":"10.18632\/oncotarget.6022","volume":"6","author":"S Yu","year":"2015","unstructured":"Yu S et al (2015) Tumor-derived exosomes in cancer progression and treatment failure. Oncotarget 6(35):37151\u201337168","journal-title":"Oncotarget"},{"key":"5563_CR291","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.887518","author":"H Wang","year":"2022","unstructured":"Wang H, You Y, Zhu X (2022) The role of exosomes in the progression and therapeutic resistance of hematological malignancies. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.887518","journal-title":"Front Oncol"},{"issue":"8","key":"5563_CR292","first-page":"1041","volume":"36","author":"WT Zhao","year":"2020","unstructured":"Zhao WT et al (2020) Research progress of exosomal ncRNAs in hepatocellular carcinoma. Chin Pharmacol Bull 36(8):1041\u20131044","journal-title":"Chin Pharmacol Bull"},{"issue":"9","key":"5563_CR293","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","volume":"33","author":"R Isaac","year":"2021","unstructured":"Isaac R et al (2021) Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab 33(9):1744\u20131762","journal-title":"Cell Metab"},{"key":"5563_CR294","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115087","author":"J Li","year":"2023","unstructured":"Li J et al (2023) A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2023.115087","journal-title":"Biomed Pharmacother"},{"key":"5563_CR295","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","volume":"174","author":"L Barile","year":"2017","unstructured":"Barile L, Vassalli G (2017) Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther 174:63\u201378","journal-title":"Pharmacol Ther"},{"key":"5563_CR296","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.plipres.2017.03.001","volume":"66","author":"T Skotland","year":"2017","unstructured":"Skotland T, Sandvig K, Llorente A (2017) Lipids in exosomes: current knowledge and the way forward. Prog Lipid Res 66:30\u201341","journal-title":"Prog Lipid Res"},{"issue":"1","key":"5563_CR297","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1194\/jlr.R084343","volume":"60","author":"T Skotland","year":"2019","unstructured":"Skotland T et al (2019) Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res 60(1):9\u201318","journal-title":"J Lipid Res"},{"key":"5563_CR298","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041415","author":"T Skotland","year":"2023","unstructured":"Skotland T, Llorente A, Sandvig K (2023) Lipids in extracellular vesicles: what can be learned about membrane structure and function? Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a041415","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5563_CR299","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.acr.2018.05.004","volume":"140","author":"A Elsherbini","year":"2018","unstructured":"Elsherbini A, Bieberich E (2018) Ceramide and exosomes: a novel target in cancer biology and therapy. Adv Cancer Res 140:121\u2013154","journal-title":"Adv Cancer Res"},{"issue":"3","key":"5563_CR300","first-page":"435","volume":"86","author":"MA Hasnat","year":"2024","unstructured":"Hasnat MA et al (2024) Crucial roles of exosomes secreted from ganglioside GD3\/GD2-positive glioma cells in enhancement of the malignant phenotypes and signals of GD3\/GD2-negative glioma cells. Nagoya J Med Sci 86(3):435\u2013451","journal-title":"Nagoya J Med Sci"},{"issue":"1","key":"5563_CR301","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12987-025-00651-y","volume":"22","author":"K Li","year":"2025","unstructured":"Li K et al (2025) Reactive astrocyte-derived exosomes enhance intracranial lymphatic drainage in mice after intracranial hemorrhage. Fluids Barriers CNS 22(1):37","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"5563_CR302","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-024-01072-z","volume":"31","author":"L Delila","year":"2024","unstructured":"Delila L et al (2024) Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson\u2019s disease models. J Biomed Sci 31(1):87","journal-title":"J Biomed Sci"},{"issue":"2","key":"5563_CR303","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/glia.24478","volume":"72","author":"V Mattera","year":"2024","unstructured":"Mattera V et al (2024) Remyelinating effect driven by transferrin-loaded extracellular vesicles. Glia 72(2):338\u2013361","journal-title":"Glia"},{"key":"5563_CR304","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107207","volume":"90","author":"A Fathollahi","year":"2021","unstructured":"Fathollahi A et al (2021) Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis. Int Immunopharmacol 90:107207","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"5563_CR305","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4103\/NRR.NRR-D-23-01889","volume":"20","author":"C Wang","year":"2025","unstructured":"Wang C et al (2025) Human-induced pluripotent stem cell-derived neural stem cell exosomes improve blood-brain barrier function after intracerebral hemorrhage by activating astrocytes via PI3K\/AKT\/MCP-1 axis. Neural Regen Res 20(2):518\u2013532","journal-title":"Neural Regen Res"},{"key":"5563_CR306","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115143","volume":"386","author":"S Gotoh","year":"2025","unstructured":"Gotoh S, Kawabori M, Yamaguchi S, Nakahara Yo, Yoshie E, Konno K, Mizuno Y, Fujioka Y, et al. (2025) Intranasal administration of stem cell-derived exosome alleviates cognitive impairment against subarachnoid hemorrhage. Exp Neurol 386:115143. https:\/\/doi.org\/10.1016\/j.expneurol.2025.115143","journal-title":"Exp Neurol"},{"issue":"34","key":"5563_CR307","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504486","volume":"12","author":"Y Wang","year":"2025","unstructured":"Wang Y et al (2025) Nasal delivery of engineered exosomes via a thermo-sensitive hydrogel depot reprograms glial cells for spinal cord repair. Adv Sci Weinh 12(34):e04486","journal-title":"Adv Sci Weinh"},{"key":"5563_CR308","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ceb.2014.05.004","volume":"29","author":"J Kowal","year":"2014","unstructured":"Kowal J, Tkach M, Th\u00e9ry C (2014) Biogenesis and secretion of exosomes. Curr Opin Cell Biol 29:116\u2013125","journal-title":"Curr Opin Cell Biol"},{"key":"5563_CR309","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-981-99-8373-5_2","volume-title":"Exosomes based drug delivery strategies for brain disorders","author":"K Parameshwar","year":"2024","unstructured":"Parameshwar K et al (2024) Exosomes: biogenesis, composition, and synthesis. In: Mishra N et al (eds) Exosomes based drug delivery strategies for brain disorders. Springer Nature Singapore, Singapore, pp 37\u201353"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05563-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05563-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05563-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:10:19Z","timestamp":1764267019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05563-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":309,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5563"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05563-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"193"}}